LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

A reliable and accessible approach using a simple blood draw to detect hepatocellular carcinoma in cirrhotic patients has been validated in a clinical trial with promising results. More...
14 Jun 2024
Image: The Hairpin Duplex Enhanced Fidelity Sequencing (HiDEF-seq) could reveal the causes of mutations (Photo courtesy of Shutterstock)

New Technique Reveals Earliest Signs of Genetic Mutations

A new study has introduced a groundbreaking technique that can accurately identify early molecular changes in the DNA code that precede mutations. More...
14 Jun 2024
Image: The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test runs on the cobas liat system (Photo courtesy of Roche)

Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes

A new diagnostic test employs sensitive PCR technology and requires just a single nasal swab sample to quickly and accurately identify and differentiate among four major respiratory viruses, guiding appropriate treatment decisions. More...
13 Jun 2024
Image: Screening for prostate cancer with first-line MRI is less cost-effective than first-line PSA testing (Photo courtesy of Adobe Stock)

First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening

A cost-effectiveness analysis has revealed that using biparametric MRI as an initial screening tool is less cost-effective than the traditional approach of first-line PSA testing followed by multiparametric MRI. More...
12 Jun 2024
Image: The Olink Explore platform can identify proteins in blood that may provide a 7-year warning for various cancers (Photo courtesy of Olink Holding)

Proteomics Platform Identifies Proteins in Blood to Give Cancer Warning 7 Years before Diagnosis

Researchers have employed a cutting-edge proteomics platform to identify blood proteins that could potentially provide a seven-year advance warning for various types of cancer. More...
11 Jun 2024
Image: Illustration representing DELFI approach for lung cancer detection (Photo courtesy of Cancer Discovery)

AI Technology-Based Blood Test Identifies Lung Cancer Earlier

Researchers have leveraged AI to spot patterns of DNA fragments linked to lung cancer, which has led to the development and validation of a liquid biopsy that could identify the disease earlier. More...
10 Jun 2024
Image: The ultra-sensitive blood test detects tiny amounts of cancer DNA left in the body after treatment for early breast cancer (Photo courtesy of ICR)

Ultra-Sensitive Blood Test Predicts Breast Cancer Recurrence Months or Even Years before Relapse

A new type of blood test can predict breast cancer recurrence in high-risk patients who have undergone surgery or other treatments months or even years before relapse occurs. More...
07 Jun 2024
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
INTEGRA BIOSCIENCES AG